La Fleur & Godfrey LLC Exact Sciences Corp Transaction History

La Fleur & Godfrey LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$59.06 - $75.72 $2,657 - $3,407	-45 Reduced 1.36%	3,260 $241,000
Q3 2023 Oct 18, 2023	SELL	$65.94 - $99.04 $18,133 - $27,236	-275 Reduced 7.68%	3,305 $225,000
Q2 2023 Jul 20, 2023	BUY	$62.68 - $95.05 $224,394 - $340,279	3,580 New	3,580 $336,000
Q2 2022 Jul 26, 2022	SELL	$35.61 - $76.23 $282,565 - $604,885	-7,935 Reduced 60.01%	5,287 $208,000
Q1 2022 May 03, 2022	SELL	$57.56 - $82.54 $467,272 - $670,059	-8,118 Reduced 38.04%	13,222 $924,000
Q4 2021 Jan 26, 2022	BUY	$72.5 - $100.68 $344,375 - $478,230	4,750 Added 28.63%	21,340 $1.66 Million
Q3 2021 Nov 01, 2021	BUY	$90.24 - $124.05 $1.15 Million - $1.59 Million	12,785 Added 336.01%	16,590 $1.58 Million
Q2 2021 Jul 19, 2021	BUY	$93.66 - $139.27 $356,376 - $529,922	3,805 New	3,805 $473,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of La Fleur & Godfrey LLC, based on Form 13F filings with the SEC.

Stay updated on La Fleur & Godfrey LLC with notifications on news.